Pfizer, Inc. (NYSE: PFE) reported Q4 EPS of $0.56, $0.04 better than the analyst estimate of $0.52. Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE